Novartis AG - stock earnings
NVS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 8.5 billion USD | 11.8 billion USD |
| 2023Q3 | 1.8 billion USD | 12.1 billion USD |
| 2023Q2 | 2.3 billion USD | 13.9 billion USD |
| 2023Q1 | 2.3 billion USD | 13.2 billion USD |
| 2022Q4 | 1.5 billion USD | 13.1 billion USD |
| 2022Q3 | 1.6 billion USD | 12.8 billion USD |
| 2022Q2 | 1.7 billion USD | 13.1 billion USD |
| 2022Q1 | 2.2 billion USD | 12.8 billion USD |
| 2021Q4 | 16.3 billion USD | 13.5 billion USD |
| 2021Q3 | 2.8 billion USD | 13.4 billion USD |
| 2021Q2 | 2.9 billion USD | 13.3 billion USD |
| 2021Q1 | 2.1 billion USD | 12.7 billion USD |
| 2020Q4 | 2.1 billion USD | 13.0 billion USD |
| 2020Q3 | 1.9 billion USD | 12.5 billion USD |
| 2020Q2 | 1.9 billion USD | 11.6 billion USD |
| 2020Q1 | 2.2 billion USD | 12.7 billion USD |
| 2019Q4 | 1.1 billion USD | 12.7 billion USD |
| 2019Q3 | 2.0 billion USD | 12.5 billion USD |
| 2019Q2 | 6.8 billion USD | 12.0 billion USD |
| 2019Q1 | 1.8 billion USD | 11.5 billion USD |
| 2018Q4 | 1.2 billion USD | 13.7 billion USD |
| 2018Q3 | 1.6 billion USD | 11.4 billion USD |
| 2018Q2 | 7.8 billion USD | 13.5 billion USD |
| 2018Q1 | 2.0 billion USD | 12.9 billion USD |
| 2017Q4 | 2.0 billion USD | 13.2 billion USD |
| 2017Q3 | 2.1 billion USD | 12.7 billion USD |
| 2017Q2 | 2.0 billion USD | 12.5 billion USD |
| 2017Q1 | 1.7 billion USD | 11.8 billion USD |
| 2016Q4 | 957.0 million USD | 12.6 billion USD |
| 2016Q3 | 1.9 billion USD | 12.3 billion USD |
| 2016Q2 | 1.8 billion USD | 12.7 billion USD |
| 2016Q1 | 2.0 billion USD | 11.8 billion USD |
| 2015Q4 | 1.1 billion USD | 12.8 billion USD |
| 2015Q3 | 1.9 billion USD | 12.5 billion USD |
| 2015Q2 | 1.8 billion USD | 12.9 billion USD |
| 2015Q1 | 13.0 billion USD | 12.2 billion USD |
| 2014Q4 | 1.5 billion USD | 13.4 billion USD |
| 2014Q3 | 3.2 billion USD | 13.3 billion USD |
| 2014Q2 | 2.6 billion USD | 13.9 billion USD |
| 2014Q1 | 2.9 billion USD | 14.2 billion USD |
| 2013Q4 | 2.0 billion USD | 15.4 billion USD |
| 2013Q3 | 2.2 billion USD | 14.6 billion USD |
| 2013Q2 | 2.5 billion USD | 14.7 billion USD |
| 2013Q1 | 2.4 billion USD | 14.2 billion USD |
| 2012Q4 | 2.0 billion USD | 15.1 billion USD |
| 2012Q3 | 2.4 billion USD | 14.0 billion USD |
| 2012Q2 | 2.7 billion USD | 14.5 billion USD |
| 2012Q1 | 2.3 billion USD | 13.9 billion USD |
| 2011Q4 | 1.2 billion USD | 15.0 billion USD |
| 2011Q3 | 2.5 billion USD | 15.0 billion USD |
| 2011Q2 | 2.7 billion USD | 15.1 billion USD |
| 2011Q1 | 2.8 billion USD | 14.2 billion USD |
| 2010Q4 | 2.2 billion USD | 14.5 billion USD |
| 2010Q3 | 2.3 billion USD | 12.8 billion USD |
| 2010Q2 | 2.4 billion USD | 11.9 billion USD |
| 2010Q1 | 2.9 billion USD | 12.4 billion USD |
| 2009Q4 | 2.3 billion USD | 13.1 billion USD |
| 2009Q3 | 2.1 billion USD | 11.3 billion USD |
| 2009Q2 | 2.0 billion USD | 10.7 billion USD |
| 2009Q1 | 2.0 billion USD | 9.9 billion USD |
| 2008Q4 | 1.5 billion USD | 10.3 billion USD |
| 2008Q3 | 2.1 billion USD | 11.0 billion USD |
| 2008Q2 | 2.2 billion USD | 10.7 billion USD |
| 2008Q1 | 2.3 billion USD | 10.2 billion USD |
| 2007Q4 | 904.0 million USD | 10.2 billion USD |
| 2007Q3 | 6.9 billion USD | 9.8 billion USD |
| 2007Q2 | 2.0 billion USD | 9.4 billion USD |
| 2007Q1 | 2.2 billion USD | 9.8 billion USD |
| 2006Q4 | 1.7 billion USD | 9.3 billion USD |
| 2006Q3 | 1.9 billion USD | 9.7 billion USD |
| 2006Q2 | 1.7 billion USD | 9.2 billion USD |
| 2006Q1 | 1.9 billion USD | 8.3 billion USD |
| 2005Q4 | 1.4 billion USD | 8.8 billion USD |
| 2005Q3 | 1.7 billion USD | 8.5 billion USD |
| 2005Q2 | 1.6 billion USD | 7.9 billion USD |
| 2005Q1 | 1.5 billion USD | 7.3 billion USD |
| 2004Q4 | 1.4 billion USD | 7.6 billion USD |
| 2004Q3 | 1.5 billion USD | 7.1 billion USD |
| 2004Q2 | 1.5 billion USD | 7.0 billion USD |
| 2004Q1 | 1.3 billion USD | 6.6 billion USD |
| 2003Q4 | 1.4 billion USD | 6.7 billion USD |
| 2003Q3 | 1.3 billion USD | 6.2 billion USD |
| 2003Q2 | 1.3 billion USD | 6.2 billion USD |
| 2003Q1 | 1.1 billion USD | 5.7 billion USD |
| 2002Q4 | 1.7 billion USD | 7.8 billion USD |
| 2002Q3 | 1.1 billion USD | 5.1 billion USD |
| 2002Q2 | 1.4 billion USD | 5.6 billion USD |
| 2002Q1 | 1.1 billion USD | 4.9 billion USD |
| 2001Q4 | 1.0 billion USD | 5.1 billion USD |
| 2001Q3 | 1.1 billion USD | 5.6 billion USD |
| 2001Q2 | 1.0 billion USD | 4.3 billion USD |
| 2001Q1 | 1.1 billion USD | 6.0 billion USD |
| 2000Q4 | 1.1 billion USD | 6.0 billion USD |
| 2000Q3 | 876.0 million USD | 4.9 billion USD |
| 2000Q2 | 1.3 billion USD | 5.8 billion USD |
| 2000Q1 | 1.3 billion USD | 5.7 billion USD |
NVS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 14.9 billion USD | 46.7 billion USD |
| 2022 | 7.0 billion USD | 51.8 billion USD |
| 2021 | 24.0 billion USD | 52.9 billion USD |
| 2020 | 8.1 billion USD | 49.9 billion USD |
| 2019 | 7.1 billion USD | 48.7 billion USD |
| 2018 | 12.6 billion USD | 53.2 billion USD |
| 2017 | 7.7 billion USD | 50.1 billion USD |
| 2016 | 6.7 billion USD | 49.4 billion USD |
| 2015 | 17.8 billion USD | 50.4 billion USD |
| 2014 | 10.2 billion USD | 53.6 billion USD |
| 2013 | 9.2 billion USD | 58.8 billion USD |
| 2012 | 9.5 billion USD | 57.6 billion USD |
| 2011 | 9.1 billion USD | 59.4 billion USD |
| 2010 | 9.8 billion USD | 51.6 billion USD |
| 2009 | 8.4 billion USD | 45.1 billion USD |
| 2008 | 8.2 billion USD | 42.6 billion USD |
| 2007 | 11.9 billion USD | 38.9 billion USD |
| 2006 | 7.2 billion USD | 36.7 billion USD |
| 2005 | 6.1 billion USD | 32.5 billion USD |
| 2004 | 5.8 billion USD | 28.2 billion USD |
| 2003 | 5.0 billion USD | 24.9 billion USD |
| 2002 | 5.2 billion USD | 23.2 billion USD |
| 2001 | 4.2 billion USD | 19.3 billion USD |
| 2000 | 4.4 billion USD | 21.8 billion USD |
| 1999 | 4.2 billion USD | 20.4 billion USD |
| 1998 | 4.4 billion USD | 23.0 billion USD |
NVS
List: Challengers
Price: $97.44
52 week price:
Dividend Yield: 3.84%
5-year range yield:
Forward Dividend Yield: 3.88%
Payout Ratio: 92.13%
Payout Ratio Range:
Dividend Per Share: 3.78 USD
Earnings Per Share: 4.10 USD
P/E Ratio: 24.72
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.7 million
Ebitda: 2.5 billionMarket Capitalization: 200.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 28
DGR3: 4.59%
DGR5: 5.70%
DGR10: 4.54%
DGR20: 9.41%